| Bioactivity | Saterinone is a phosphodiesterase III (PDE III) inhibitor. |
| Target | phosphodiesterase III (PDE III) |
| Invitro | Saterinone combines direct positive inotropic action with pronounced vasodilating properties partly due to an alpha-receptor antagonism of its urapidil-like moiety in the molecular structure[1]. MCE has not independently confirmed the accuracy of these methods. They are for reference only. 0 --> Saterinone 相关抗体: |
| CAS | 102669-89-6 |
| Formula | C27H30N4O4 |
| Molar Mass | 474.55 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Kieback AG, et al. Pharmacokinetics and hemodynamic effects of the phosphodiesterase III inhibitor saterinone in patients with chronic heart failure. Int J Cardiol. 2003 Oct;91(2-3):201-8. |